The aim of this phase II trial was to assess the efficacy and tolerability of docetaxel/vinorelbine as second-line therapy. Thirty-two patients with a performance status (PS) of

Download full-text PDF

Source
http://dx.doi.org/10.3816/clc.2002.n.024DOI Listing

Publication Analysis

Top Keywords

phase study
4
study docetaxel/vinorelbine
4
docetaxel/vinorelbine patients
4
patients non-small-cell-lung
4
non-small-cell-lung cancer
4
cancer treated
4
treated platinum-based
4
platinum-based chemotherapy
4
chemotherapy aim
4
aim phase
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!